Quantum Discovery Labs » Quantum Software http://q-pharm.com The drug discovery company Fri, 02 Mar 2012 06:38:21 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 Beefing up the pipeline: new leads against influenza virus identified http://q-pharm.com/2010/09/beefing-up-the-pipeline-new-leads-against-influenza-virus-identified/ http://q-pharm.com/2010/09/beefing-up-the-pipeline-new-leads-against-influenza-virus-identified/#comments Mon, 20 Sep 2010 07:49:30 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=317
  • Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
  • Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo
  • New inhibitors of RecA (bacterial SOS response system) identified.
    • ]]>     http://q-pharm.com/2010/09/beefing-up-the-pipeline-new-leads-against-influenza-virus-identified/feed/ 0     Application of a novel in silico high throughput screen to identify selective inhibitors for protein–protein interactions http://q-pharm.com/2010/08/application-of-a-novel-in-silico-high-throughput-screen-to-identify-selective-inhibitors-for-protein%e2%80%93protein-interactions/ http://q-pharm.com/2010/08/application-of-a-novel-in-silico-high-throughput-screen-to-identify-selective-inhibitors-for-protein%e2%80%93protein-interactions/#comments Thu, 05 Aug 2010 15:05:38 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=334
  • Quantum announce collaboration with University of Colorado at Boulder
  • High Throughput Screening of Transcription factor DLX5
  • Virtual High Throughput Screening
  • Drug Discovery: identifying potential therapeutics that inhibit opioids-induced glial cell activation
  • Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
    • ]]>     http://q-pharm.com/2010/08/application-of-a-novel-in-silico-high-throughput-screen-to-identify-selective-inhibitors-for-protein%e2%80%93protein-interactions/feed/ 0     New inhibitors of RecA (bacterial SOS response system) identified. http://q-pharm.com/2010/07/new-inhibitors-of-reca-bacterial-sos-response-system-identified/ http://q-pharm.com/2010/07/new-inhibitors-of-reca-bacterial-sos-response-system-identified/#comments Wed, 14 Jul 2010 07:29:11 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=306 http://q-pharm.com/2010/07/new-inhibitors-of-reca-bacterial-sos-response-system-identified/feed/ 2 Drug resistance: evolution in action http://q-pharm.com/2010/01/drug-resistance-evolution-in-action/ http://q-pharm.com/2010/01/drug-resistance-evolution-in-action/#comments Wed, 06 Jan 2010 08:40:08 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=176
  • MA/p17 HIV matrix protein is a promising target for drug discovery
  • What’s an ultimate value of reversible drug binding constant?
    • ]]>     http://q-pharm.com/2010/01/drug-resistance-evolution-in-action/feed/ 1     Free energy perturbation theory for accurate IC50 calculations http://q-pharm.com/2009/06/free-energy-perturbation-theory-for-accurate-ic50-calculations/ http://q-pharm.com/2009/06/free-energy-perturbation-theory-for-accurate-ic50-calculations/#comments Sat, 27 Jun 2009 08:28:08 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=78
  • QUANTUM free energy vs. statistical scoring functions
  • QUANTUM and HSA binding calculations: the role of protein flexibility
  • Self-consistent solvation energy contribution calculation for protein-ligand complexes
  • Solvation energy of a large atom cluster: continuous solvation energy test – II
  • Solvation energy of a diatomic molecule: continuous solvation energy test – I
    • ]]>     http://q-pharm.com/2009/06/free-energy-perturbation-theory-for-accurate-ic50-calculations/feed/ 0